GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Zenlabs Ethica Ltd (BOM:530697) » Definitions » 10-Year RORE %

Zenlabs Ethica (BOM:530697) 10-Year RORE % : 17.32% (As of Dec. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Zenlabs Ethica 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Zenlabs Ethica's 10-Year RORE % for the quarter that ended in Dec. 2024 was 17.32%.

The industry rank for Zenlabs Ethica's 10-Year RORE % or its related term are showing as below:

BOM:530697's 10-Year RORE % is ranked better than
67.65% of 68 companies
in the Medical Distribution industry
Industry Median: 9.005 vs BOM:530697: 17.32

Zenlabs Ethica 10-Year RORE % Historical Data

The historical data trend for Zenlabs Ethica's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenlabs Ethica 10-Year RORE % Chart

Zenlabs Ethica Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 57.36 24.95 14.90 12.01

Zenlabs Ethica Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 12.01 12.39 11.23 17.32

Competitive Comparison of Zenlabs Ethica's 10-Year RORE %

For the Medical Distribution subindustry, Zenlabs Ethica's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zenlabs Ethica's 10-Year RORE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Zenlabs Ethica's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where Zenlabs Ethica's 10-Year RORE % falls into.


;
;

Zenlabs Ethica 10-Year RORE % Calculation

Zenlabs Ethica's 10-Year RORE % for the quarter that ended in Dec. 2024 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( 0.51--0.771 )/( 7.882-0.488 )
=1.281/7.394
=17.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2024 and 10-year before.


Zenlabs Ethica  (BOM:530697) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Zenlabs Ethica 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of Zenlabs Ethica's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zenlabs Ethica Business Description

Traded in Other Exchanges
N/A
Address
Plot No.194-195, 3rd Floor, Industrial Area, Phase-II, Ram Darbar, Chandigarh, IND, 160002
Zenlabs Ethica Ltd is a pharmaceutical company engaged in the trading of pharmaceutical formulations. It manufactures and markets drugs which include Gastrointestinal disorders, anti-diabetics, anti-hypertensive drugs, anti-infective, soaps, and anti-Bacterial drugs, nutraceuticals, and others. In addition, The company offers more than 600 products across therapeutic segments.

Zenlabs Ethica Headlines

No Headlines